Generate Biomedicines' Andover Campus Hits 100% Occupancy with 128,000 Sq Ft AdvanCell Lease
GENB•Innovation Park in Andover now stands 100% leased after AdvanCell signed a 128,000 sq ft long-term lease, joining Generate Biomedicines in the 340,000 sq ft campus featuring cGMP facilities and amenities. The fully occupied park secures dedicated manufacturing and infrastructure, enhancing operational stability for Generate Biomedicines.
1. AdvanCell Lease Completes Phase 2 Occupancy
AdvanCell signed a long-term lease for the entire 128,000 sq ft 1 Corporate Drive building at Innovation Park Phase 2 in Andover, bringing the newly completed phase to full occupancy. This major life-science transaction underscores robust demand for ready-to-use advanced manufacturing space in the region.
2. Generate Biomedicines on Campus
Generate Biomedicines, a Flagship Pioneering spinout that completed a $400 million IPO in February 2026, occupies the adjacent building at Innovation Park. Full campus occupancy guarantees its access to shared utilities, talent pools and dedicated cGMP manufacturing support.
3. Amenities and Infrastructure
Innovation Park offers best-in-class amenities including a full-service café, high-end fitness center, communal conferencing, EV charging and 24/7 facility management. Turnkey Grade B, C and D clean rooms, labs, offices and warehouse areas accelerate speed-to-market for integrated life-science manufacturing operations.
4. Remaining Availability and Market Outlook
Innovation Park’s total 340,000 sq ft footprint is now nearly sold out after Phase 2 reached 100% leasing. Only 137,000 sq ft of turnkey cGMP space at 4 Corporate Drive remains, highlighting sustained demand in the Greater Boston advanced manufacturing corridor.
